Chemokine CC Receptor Antagonists
| Cat. No. | Product Name / Activity |
|---|---|
| 6541 | AZD 2098 |
| Potent and selective CCR4 antagonist | |
| 6141 | BI-6901 |
| Potent and selective CCR10 antagonist | |
| 3129 | BMS CCR2 22 |
| High affinity, potent CCR2 antagonist | |
| 3496 | BX 471 |
| Potent, selective CCR1 antagonist | |
| 2769 | BX 513 hydrochloride |
| Selective CCR1 antagonist | |
| 3581 | C 021 dihydrochloride |
| Potent CCR4 antagonist | |
| 7071 | GSK 2239633A |
| Potent CCR4 antagonist | |
| 4306 | INCB 3284 dimesylate |
| Selective CCR2 antagonist | |
| 2595 | J 113863 |
| Potent CCR1 chemokine receptor antagonist | |
| 3756 | Maraviroc |
| Selective CCR5 antagonist | |
| 2089 | RS 102895 hydrochloride |
| CCR2b chemokine receptor antagonist | |
| 2517 | RS 504393 |
| Highly selective CCR2 chemokine receptor antagonist | |
| 4213 | SB 297006 |
| Potent and selective CCR3 antagonist | |
| 3650 | SB 328437 |
| Potent and selective CCR3 antagonist | |
| 4340 | TAK 779 |
| Potent and selective CCR5 and CCR2 chemokine receptor antagonist | |
| 2757 | UCB 35625 |
| Potent CCR1 and CCR3 antagonist |
Rheumatoid Arthritis Life Science Poster
Written by Adam P. Cribbs et al.
Our Rheumatoid Arthritis poster summarizes the disease pathology and highlights some of the epigenetic modifications associated with the condition.
Request copyDownload PDF